Form 4: Silicon Laboratories Director Christy Wyatt Sells Shares Under 10b5-1 Trading Plan

Director Christy Wyatt sold 546 shares of Silicon Laboratories (SLAB) at $104.45 per share on May 6, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On May 6, 2025, Christy Wyatt, a director of Silicon Laboratories Inc. (SLAB), sold 546 shares of common stock at a price of $104.45 per share.
• The sale was executed under a pre-arranged 10b5-1 trading plan.
• Following the transaction, Wyatt directly owns 8,492 shares of Silicon Laboratories.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document reports a routine stock sale by a company director under a pre-arranged trading plan, which is generally neutral in sentiment.

Industry Context

Sales by insiders are common and often pre-planned, especially through 10b5-1 trading plans, which allow insiders to sell shares at predetermined times and prices to avoid accusations of insider trading. The market typically views these sales as routine unless the size or frequency is unusual.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder confidence, but is unlikely to be significant given the use of a 10b5-1 trading plan.

Key Dates

Keywords

Form 4, Silicon Laboratories, SLAB, Christy Wyatt, Stock Sale, 10b5-1 Trading Plan, Director